A world-first initiative to boost partnership between academics, clinicians and the life sciences industry includes Nottingham amongst the country’s first centres of excellence. Setting Nottingham respiratory research within a premier grouping of leading biomedical centres, the partnership will provide the right commercial and cultural environment to maintain and grow world-class research and development.
The Respiratory Capability Cluster develops the three-way partnership between the life sciences industry, clinicians and academics. Together they will develop the best approaches to find novel ways of diagnosing and treating a whole range of respiratory diseases.
Nottingham University Hospitals in partnership with the University of Nottingham is one of nine centres in the UK to participate in the Cluster. These clusters are the first in the world to be established around specific therapy areas.
Announcing the national programme, Minister for Universities and Science David Willetts said:
“I am hugely excited by the potential they offer for UK R&D and our delivery of innovative medicines to patients faster in areas of unmet medical need.“
NUH Director of R&D, Dr Brian Thomson said:
“This relationship between the NHS, Academia and the life sciences industry is precisely the innovation model we have been striving to promote for Nottingham. It presents a perfect opportunity to coalesce our efforts around the ideal partnership structure for biomedical sciences, starting with respiratory diseases.”
Professor Alan Knox, Nottingham University Professor of Respiratory Medicine and Director of the Nottingham Respiratory Biomedical Research Unit added:
“This is an exciting opportunity to develop new treatments for patients with lung diseases.”
Developed with industry under the Office for Life Sciences, the Therapeutic Capability Clusters programme is being overseen by the Office for Strategic Coordination of Health and Research (OSCHR).